ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,167.60
      0.00%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.195
      0.09%
      Bitcoin
      66,244.69
      -0.59%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Novavax Inc (NVAX)

      7. Novavax Inc (NVAX) News

      NVAX

      Novavax (NVAX)

      Novavax Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NVAX
      DateTimeSourceHeadlineSymbolCompany
      06/14/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      06/14/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      06/14/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      06/14/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      06/14/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      06/14/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      06/14/20244:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      06/14/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
      06/14/20242:05PMPR Newswire (US)Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccineNASDAQ:NVAXNovavax Inc
      06/06/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
      06/04/20249:35PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
      05/30/20249:25AMPR Newswire (US)Novavax to Participate in 2024 Jefferies Global Healthcare ConferenceNASDAQ:NVAXNovavax Inc
      05/23/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
      05/20/20242:42PMEdgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
      05/20/20246:35AMGlobeNewswire Inc.Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual MeetingNASDAQ:NVAXNovavax Inc
      05/20/20246:09AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NVAXNovavax Inc
      05/15/20249:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
      05/14/20245:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVAXNovavax Inc
      05/13/20244:10PMEdgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
      05/13/20244:02PMPR Newswire (US)Novavax to Participate in BofA Securities 2024 Health Care ConferenceNASDAQ:NVAXNovavax Inc
      05/13/20242:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
      05/10/20248:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
      05/10/20248:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
      05/10/20248:02AMIH Market NewsNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More NewsNASDAQ:NVAXNovavax Inc
      05/10/20242:15AMPR Newswire (US)Novavax Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
      05/10/20242:00AMPR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:NVAXNovavax Inc
      05/08/20244:53PMEdgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
      05/07/20245:21PMEdgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
      05/07/20242:43PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NVAXNovavax Inc
      05/07/20249:25AMPR Newswire (US)Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024NASDAQ:NVAXNovavax Inc
       Showing the most relevant articles for your search:NASDAQ:NVAX